Sotera Health (SHC) PT Raised to $22 at Barclays
Tweet
Share
E-mailGet Alerts SHC Hot Sheet
Price: $18.70 -0.16%
Rating Summary:
11 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Rating Summary:
11 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 28
Join SI Premium – FREE
Barclays analyst Luke Sergott raised the price target on Sotera Health (NASDAQ: SHC) to $22.00 (from $19.00) while maintaining a Overweight rating.
You May Also Be Interested In
- BofA Securities Upgrades Candel Therapeutics Inc. (CADL) to Buy
- Teradata (TDC) PT Lowered to $32 at UBS on Cautious Q3 View
- Adeptus Biotechnologies Corp. (ADPT) PT Raised to $34 at BTIG
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
